ScreenPoint Medical: AI-Enhanced Mammography Screening Significantly Improves Breast Cancer Detection and Reduces Radiologist Workload
Groundbreaking Randomized MASAI Trial Demonstrates Transpara plays a vital role in improving early detection, leading to better outcomes and more efficient use of radiologist time NIJMEGEN, The Netherlands, Feb. 5, 2025 – Results of a groundbreaking, randomized trial involving more than 105,000 women reveals that the use of artificial intelligence (AI) in mammography screening significantly increases cancer […]
ScreenPoint Medical Acquires Biomediq A/S to Expand Breast Cancer Risk Assessment Capabilities
Research Published in Radiology Shows that Combination of Transpara-based Lesion Detection, Volumetric Density and Quantitative Texture Analysis Delivers Improved Breast Cancer Risk Prediction NIJMEGEN, The Netherlands, January 8, 2025 – ScreenPoint Medical today announced the acquisition of Biomediq A/S, a research-based company focused on the research, development and implementation of quantitative imaging biomarkers. After a decade […]
Transpara may have detected Karin Boxem’s breast cancer years earlier, potentially preventing her from a mastectomy.
Nijmegen, The Netherlands, November 12, 2024 – In a powerful front-page story in De Telegraaf, Karin Boxem, 56, from Giesbeek, the Netherlands, reflects on how AI could have changed her cancer journey. Six years ago, Boxem was screened for the first time in the Dutch National Breast Cancer Screening Programme. Shortly afterwards, she received her […]
